AviadoBio at Cell 2026
Nov 12–13, 2026 London, UK ~800 attendees Website
AviadoBio takes part in 3 sessions at Cell 2026 in London, its home city. Its sessions centre on delivering gene therapies inside the body and on RNA silencing as a platform for rare disease. The most concrete topic is manufacturing an AAV vector built to cross the blood-brain barrier and silence the MAPT gene in Alzheimer's disease.
| Organization | Cell 2026 Attendance |
|---|---|
AviadoBio London, UK | |
King's College London spin-out developing gene therapies for neurodegenerative diseases such as frontotemporal dementia. | Panel Thu Nov 12 12:25pm–12:50pm Cracking In Vivo Delivery For Next-Generation Gene Therapies Cell and gene therapy Talk Thu Nov 12 2:40pm–3:05pm Manufacture Of AVB-406, A BBB-Crossing AAV Vector For MAPT Knockdown In Alzheimer's Disease Cell and gene therapyManufacturing and CMC Talk Thu Nov 12 5:45pm–6:10pm |
Instantly find 20 buyers from AviadoBio
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with or endorsed by Cell 2026 or its organizers. Submit a correction